IgMκ and IgMλ Measurements for the Assessment of Patients with Waldenström's Macroglobulinaemia
暂无分享,去创建一个
S. Chevret | S. Harding | H. Avet-Loiseau | X. Leleu | V. Leblond | T. Facon | G. Fouquet | E. Boyle | S. Manier | J. Lejeune | B. Hennache | S. Schraen | S. Guidez | R. Duléry | J. Gay | S. Bonnet | H. Demarquette | B. Onraed | J. Faucompré | H. Debarri
[1] A. Dispenzieri,et al. Monitoring IgA multiple myeloma: immunoglobulin heavy/light chain assays. , 2015, Clinical chemistry.
[2] S. Treon. How I treat Waldenström macroglobulinemia. , 2009, Blood.
[3] S. Harding,et al. IgA kappa/IgA lambda heavy/light chain assessment in the management of patients with IgA myeloma , 2014, Cancer.
[4] X. Leleu,et al. Comparison of Waldenstrom Macroglobulinemia Responses Using Immunoglobulin Heavy / Light Chain Analysis and Conventional Electrophoresis Techniques , 2014 .
[5] C. Kyriakou,et al. Guidelines on the diagnosis and management of Waldenström macroglobulinaemia , 2014, British journal of haematology.
[6] M. Gertz. Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management , 2013, American journal of hematology.
[7] S. Harding,et al. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients , 2012, Leukemia.
[8] S. Harding,et al. Prognostic utility of intact immunoglobulin Ig′κ/Ig′λ ratios in multiple myeloma patients , 2012, Leukemia.
[9] J. Cerhan,et al. Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS , 2013, Leukemia.
[10] M. Kersten,et al. Guideline for diagnosis and treatment of Waldenström's macroglobulinaemia. , 2013, The Netherlands journal of medicine.
[11] J. Katzmann,et al. A 71-year-old woman with multiple myeloma status after stem cell transplantation. , 2011, Clinical chemistry.
[12] M. Drayson,et al. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios. , 2009, Clinical chemistry.
[13] D. Keren. Heavy/Light-chain analysis of monoclonal gammopathies. , 2009, Clinical chemistry.
[14] E. Ryu,et al. Quantitation of serum monoclonal proteins: relationship between agarose gel electrophoresis and immunonephelometry. , 2009, Clinical chemistry.
[15] S. Treon. How I treat Waldenström macroglobulinemia. , 2009, Blood.
[16] E. Miravalles,et al. Estimation of serum M-protein concentration from polyclonal immunoglobulins: an alternative to serum protein electrophoresis and standard immunochemical procedures , 2008, Clinical chemistry and laboratory medicine.
[17] E. Kimby,et al. Update on treatment recommendations from the Third International Workshop on Waldenstrom's macroglobulinemia. , 2006, Blood.
[18] D. Keren. Serum protein electrophoresis evaluation of monoclonal gammopathies (M-proteins) , 2004 .
[19] J. Sheldon,et al. Overestimation of Monoclonal Immunoglobulin by Immunochemical Methods , 1991, Annals of clinical biochemistry.
[20] A. Shenkin,et al. Estimation of Paraproteins by Immunoturbidimetry and Electrophoresis Followed by Scanning Densitometry , 1990, Annals of clinical biochemistry.
[21] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.